Skip to main content

Carlotta Antoniotti, MD, PhD

Carlotta Antoniotti, MD, PhD, University of Pisa
Videos
06/22/2023
At the 2023 ASCO annual meeting, Carlotta Antoniotti, MD, PhD, shares data from the AtezoTRIBE study evaluating the addition of atezolizumab to FOLFOXIRI plus bevacizumab for metastatic colorectal cancer.
At the 2023 ASCO annual meeting, Carlotta Antoniotti, MD, PhD, shares data from the AtezoTRIBE study evaluating the addition of atezolizumab to FOLFOXIRI plus bevacizumab for metastatic colorectal cancer.
At the 2023 ASCO annual meeting,...
06/22/2023
Oncology